Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents.
about
Challenges in preclinical to clinical translation for anticancer carrier-mediated agents.Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.When Is It Important to Measure Unbound Drug in Evaluating Nanomedicine Pharmacokinetics?Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile.
P2860
Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Formulation and physiologic fa ...... er-mediated anticancer agents.
@en
type
label
Formulation and physiologic fa ...... er-mediated anticancer agents.
@en
prefLabel
Formulation and physiologic fa ...... er-mediated anticancer agents.
@en
P2093
P2860
P1476
Formulation and physiologic fa ...... er-mediated anticancer agents.
@en
P2093
Andrew J Madden
Andrew T Lucas
William C Zamboni
P2860
P304
P356
10.1517/17425255.2015.1057496
P407
P577
2015-07-14T00:00:00Z